Cytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

Device Code: 6248

Product Code(s): ODW

Definition: An In Vitro Diagnostic Assay For Use In Genotyping Cytochrome P450 2C9 (CYP450 2C9) Alleles. Information About The CYP2C9 Genotype May Be Used As An Aid To Clinicians In Determining Therapeutic Strategy For Medications That Are Metabolized By The CYP

Device Classification Information

Device Type ID6248
Device NameCytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Physical StateGenotyping Test System
Technical MethodUses DNA Genotyping Technology To Determine Patient Genotype At The Cytochrome P450 2C9 (CYP450 2C9) Locus.
Target AreaClinical Samples (blood, Saliva, Buccal Swab Samples)
Regulation DescriptionDrug Metabolizing Enzyme Genotyping System.
Regulation Medical SpecialtyToxicology
Review PanelToxicology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(k)
CFR Regulation Number862.3360 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeODW
GMP ExemptNo
Summary MREligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID6248
DeviceCytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Product CodeODW
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionDrug Metabolizing Enzyme Genotyping System.
CFR Regulation Number862.3360 [🔎]
TPLC Last Update: 2019-04-02 21:19:21

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.